Historical Stock Price
ENMD historical stock prices picture
ENMD (ENMD) has the following price history information. Looking back at ENMD historical stock prices for the last five trading days, on June 09, 2014, ENMD opened at $1.75, traded as high as $1.77 and as low as $1.70, and closed at $1.73. Trading volume was a total of 14.40K shares. On June 10, 2014, ENMD opened at $1.76, traded as high as $1.76 and as low as $1.73, and closed at $1.74. Trading volume was a total of 4.60K shares. On June 11, 2014, ENMD opened at $1.77, traded as high as $1.77 and as low as $1.65, and closed at $1.70. Trading volume was a total of 11.90K shares. On June 12, 2014, ENMD opened at $1.71, traded as high as $1.71 and as low as $1.66, and closed at $1.68. Trading volume was a total of 23.00K shares. On June 13, 2014, ENMD opened at $1.70, traded as high as $1.74 and as low as $1.70, and closed at $1.74. Trading volume was a total of 9.50K shares.

ENMD Historical Stock Prices By Date:

ENMD historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ENMD shares, starting with a $10,000 purchase of ENMD, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/28/2014
End date: 06/13/2014
Start price/share: $1.85
End price/share: $1.74
Dividends collected/share: $0.00
Total return: -5.95%
Annualized Gain: -47.18%
Starting investment: $10,000.00
Ending investment: $9,405.00
Years: 0.13
Date Open High Low Close Volume
06/09/2014 $1.75 $1.77 $1.70 $1.73 14.40K
06/10/2014 $1.76 $1.76 $1.73 $1.74 4.60K
06/11/2014 $1.77 $1.77 $1.65 $1.70 11.90K
06/12/2014 $1.71 $1.71 $1.66 $1.68 23.00K
06/13/2014 $1.70 $1.74 $1.70 $1.74 9.50K
EntreMed is a clinical-stage pharmaceutical company employing a drug development strategy primarily in the U.S. and China to develop targeted therapeutics designed to treat cancer and other diseases. Co.'s lead drug candidate is ENMD-2076, a selective Aurora A and angiogenic kinase inhibitor for the treatment of cancer. Co.'s other product candidates in the pipeline include 2-methoxyestrdiol (2ME2), an orally active compound for the treatment of rheumatoid arthritis treatment, and MKC-1, an orally-active, small molecule, cell cycle inhibitor with in vitro and in vivo efficacy against a range of human solid tumor cell lines, including multi-drug resistant cell lines.
Date Close
06/09/2014$1.73
06/10/2014$1.74
06/11/2014$1.70
06/12/2014$1.68
06/13/2014$1.74
ENMD is categorized under the Healthcare sector; below are some other companies in the same sector:

ENSG Historical Stock Prices
ENTA Historical Stock Prices
ENTL Historical Stock Prices
ENZ Historical Stock Prices
EPRS Historical Stock Prices
EPZM Historical Stock Prices
ERB Historical Stock Prices
ESC Historical Stock Prices
ESMC Historical Stock Prices
ESPR Historical Stock Prices

Email EnvelopeFree ENMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ENMD Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.